Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Caris Life Sciences, Inc. (CAI)

Caris Life Sciences to use investor presentation at Morgan Stanley healthcare conference

Neutral Impact 1 of 5 other Written later

Caris Life Sciences said that starting September 14, 2026, its representatives will use an investor presentation in meetings with current and potential investors at the Morgan Stanley 24th Annual Global Healthcare Conference and at other investor events. The company will post the presentation on its investor relations website. The filing contains no financial results, guidance, or new business developments, so it offers no direct read on company performance.

Key points

  • Presentation to be used starting September 14, 2026 at the Morgan Stanley 24th Annual Global Healthcare Conference
  • Company will post the Investor Presentation at investor.carislifesciences.com
  • Information is furnished under Item 7.01 and is not deemed filed under Section 18 of the Exchange Act

The filing

CompanyCaris Life Sciences, Inc. (CAI)
Form8-K, current report
Filed with the SECSep 14, 2026, 4:38 PM ET
Accession number0002019410-26-000061

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.